Reproductive System & Sexual Disorders: Current Research
Open Access

Department of Pharmacology, Hooghly B. C. Roy Institute, Hooghly, India

Publications

• Review Article   
  Real World Evidence about the Efficacy of Flibanserin in Treating Premenopausal Women with Hypoactive Sexual Desire Disorder (HSDD): The Indian Scenario
  Author(s): Raja Chakraverty*, Tatini Debnath and Jyotirmoy Bondyopadhyay
  
  The most common form of Female Sexual Dysfunction (FSD), known as Hypoactive Sexual Desire Disorder (HSDD), is exhibited in a variety of ways. According to certain ideas, HSDD is related to neurotransmitter abnormalities of a neurological component. One of the innovations in established psychological techniques was the "off-label" use of dopaminergic substances like bupropion and testosterone. Before the FDA approved the drug flibanserin to treat the disorder, no treatments were available. Based on its antagonistic tendency to serotonin specifically created for HSDD treatment, flibanserin has gained acceptability as a nonhormonal alternative. Its use has shown some observable effects, including elevated sexual drive scores and fulfilling sexual experiences. Additionally, flibanserin has lessened FSD-related distress in premenopausal women with HSDD diagnoses as well as in a .. View More»
  

  Abstract PDF